Han C W, Imamura M, Hashino S, Zhu X, Tanaka J, Imai K, Matsudaira T, Asano S
Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Bone Marrow Transplant. 1995 May;15(5):733-9.
Cyclosporin A (CsA) inhibited interleukin 2 (IL-2), IL-3, interferon gamma (IFN gamma), GM-CSF and tumor necrosis factor alpha (TNF alpha) mRNA expression in spleen cells stimulated with concavalin A (Con A) when determined by the semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) method. FK506 which has a similar immunosuppressive mechanism to that of CsA also showed the same inhibitory effects except for decreased IL-5 and IL-6 mRNA expression. In contrast, both CsA and FK506 enhanced transforming growth factor beta (TGF beta) and IL-1 beta mRNA expression. Another immunosuppressant KM2210 did not show any inhibitory effects on cytokine gene expression but rather enhanced IL-10, IL-6, TGF beta and IL-1 mRNA expression, thus suggesting that KM2210 has a completely different immunosuppressive mechanism from that of CsA and FK506. Anti-TFG beta 1 antibody abrogated the suppression by KM2210 of BALB/c anti-3H/He mixed lymphocyte reaction (MLR) whereas this antibody did not abrogate the suppression by CsA and FK506 of BALB/c anti-C3H/He MLR. These results indicate that TGF beta is one of the major cytokines in KM2210 immunosuppression, in addition to IL-10, but not in immunosuppression by CsA and FK506.
当采用半定量逆转录-聚合酶链反应(RT-PCR)法测定时,环孢菌素A(CsA)可抑制伴刀豆球蛋白A(Con A)刺激的脾细胞中白细胞介素2(IL-2)、IL-3、γ干扰素(IFNγ)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和肿瘤坏死因子α(TNFα)的mRNA表达。与CsA具有相似免疫抑制机制的FK506也表现出相同的抑制作用,但IL-5和IL-6的mRNA表达有所降低。相反,CsA和FK506均可增强转化生长因子β(TGFβ)和IL-1β的mRNA表达。另一种免疫抑制剂KM2210对细胞因子基因表达未表现出任何抑制作用,反而增强了IL-10、IL-6、TGFβ和IL-1的mRNA表达,这表明KM2210具有与CsA和FK506完全不同的免疫抑制机制。抗TFGβ1抗体可消除KM2210对BALB/c抗3H/He混合淋巴细胞反应(MLR)的抑制作用,而该抗体不能消除CsA和FK506对BALB/c抗C3H/He MLR的抑制作用。这些结果表明,TGFβ是KM2210免疫抑制作用中的主要细胞因子之一,此外还有IL-10,但不是CsA和FK506免疫抑制作用中的主要细胞因子。